Have We Reached the Floor for Inpatient Declines in Cardiovascular Services?
Editor’s Note: Josh Aaker, Project Associate, Sg2, contributed to this post.
Care redesign, treatment innovations and technology advances have certainly been at play in cardiovascular services for decades: we have witnessed the positive impact they have had for CV patients. The cardiovascular disease mortality rate has declined by 25.5% from 2005 (300 deaths/100,000 population) to 2015 (221/100,000). In addition, IP CV discharges have decreased by 25% between 2007 and 2014, through a combination of status shifts to outpatient, use of observation and improved ambulatory management of disease.
Our 2018 Impact of Change® forecast projects a 1% increase in cardiovascular IP discharges by 2028. Historic IP declines are leveling off, as rising complexity and an aging population push the limits of OP management. There are 3 major CARE Families, or disease groups, that are contributing to this trend: congestive heart failure, myocardial infarction and dysrhythmia. While these projections might be a relief to some, now may be the time to double down on ongoing efforts to improve value and to think differently about how and where you manage CV patients.
For specific 2018 Impact of Change forecasts for CV, congestive heart failure, myocardial infarction and dysrhythmia, as well as action steps to meet changing demand, read the full Expert Insight. You can also check out our on-demand Cardiovascular Landscape 2018 webinar for key trends in cardiovascular services or our Cardiovascular Service Line Forecast 2018 for help building high-performing services in the CV arena.
Not an Sg2 member? Contact us to learn more about how you can achieve optimal growth and value in your cardiovascular program.